null
ChEBI ID: 59659
Member | Definition | Role |
---|---|---|
1-hydroxypyrene | 1-Hydroxypyrene | |
1-methylpyrene | 1-Methylpyrene | |
1,3-dinitropyrene | 1,3-Dinitropyrene | |
1,6-dinitropyrene | 1,6-Dinitropyrene | |
1,6-pyrenequinone | Pyrene-1,6-dione | |
1,8-dinitropyrene | 1,8-Dinitropyrene | |
1,8-pyrenequinone | Pyrene-1,8-dione | |
2-(2-pyrenyl)acetonitrile | 2-(2-pyrenyl)acetonitrile | |
2-nitropyrene | 2-Nitropyrene | |
4-nitropyrene | 4-Nitropyrene | |
benzo(a)pyrene 7,8-dihydrodiol | Benzo[a]pyrene-7,8-diol | |
benzo(a)pyrene 7,8-oxide | Benzo[a]pyrene-7,8-oxide | |
benzo(a)pyrene-7,8-dione | An o-quinone resulting from the formal oxidation of both of the hydroxy groups of benzo[a]pyrene-cis-7,8-dihydrodiol. Benzo[a]pyrene-7,8-dione is a metabolite of the widespread carcinogen benzo[a]pyrene. | benzo[a]pyrene-7,8-dione |
cyclopenta(c,d)pyrene | Cyclopenta[cd]pyrene | |
indeno(1,2,3-cd)pyrene | Indeno[1,2,3-cd]pyrene |
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 209 (19.96) | 18.7374 |
1990's | 277 (26.46) | 18.2507 |
2000's | 272 (25.98) | 29.6817 |
2010's | 259 (24.74) | 24.3611 |
2020's | 30 (2.87) | 2.80 |
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 18 (1.46%) | 5.53% |
Reviews | 35 (2.84%) | 6.00% |
Case Studies | 1 (0.08%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 1,178 (95.62%) | 84.16% |